NORTHWEST MEDICAL LIMITED

Company Registration Number:
NI669719 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 July 2023

Period of accounts

Start date: 01 August 2022

End date: 31 July 2023

NORTHWEST MEDICAL LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2023

Balance sheet
Notes

NORTHWEST MEDICAL LIMITED

Balance sheet

As at 31 July 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets: 3 641,195 861,486
Investments: 4 1 1
Total fixed assets: 641,196 861,487
Current assets
Stocks: 7,500 190,159
Debtors:   814,444 30,328
Cash at bank and in hand: 159,662 1,483,252
Investments:   0 0
Total current assets: 981,606 1,703,739
Creditors: amounts falling due within one year: 5 (72,512) (186,495)
Net current assets (liabilities): 909,094 1,517,244
Total assets less current liabilities: 1,550,290 2,378,731
Creditors: amounts falling due after more than one year:   0 (3,124)
Provision for liabilities: 0 (168,239)
Total net assets (liabilities): 1,550,290 2,207,368
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: 1,549,290 2,206,368
Shareholders funds: 1,550,290 2,207,368

The notes form part of these financial statements

NORTHWEST MEDICAL LIMITED

Balance sheet statements

For the year ending 31 July 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 April 2024
and signed on behalf of the board by:

Name: DT Reid
Status: Director

The notes form part of these financial statements

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

2. Employees

2023 2022
Average number of employees during the period 6 12

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

3. Tangible Assets

Total
Cost £
At 01 August 2022 1,264,948
Additions 4,467
Disposals 0
Revaluations 0
Transfers 0
At 31 July 2023 1,269,415
Depreciation
At 01 August 2022 403,462
Charge for year 224,758
On disposals 0
Other adjustments 0
At 31 July 2023 628,220
Net book value
At 31 July 2023 641,195
At 31 July 2022 861,486

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

4. Fixed investments

The company has a direct interest at the balance sheet date in the following:Nuprint Medical Limited PPE ManufactureNorthern Ireland100%

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

5. Creditors: amounts falling due within one year note

Obligations under hire purchase contracts £3,123Other tax and social security £7,641Other creditors £29,001Accruals and deferred income £32,747

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

6. Financial commitments

There were no commitments, guarantees or contingencies at 31 July 2023.

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

7. Loans to directors

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

8. Related party transactions

Name of the related party: Smartegic Limited
Relationship:
Smartegic Limited
Description of the Transaction: By reason of GJ Killeen being a director of Smartegic Limited.
£
Balance at 01 August 2022 0
Balance at 31 July 2023 400,000
Name of the related party: Cosmopolitan Marketing & Operations Limited
Relationship:
Cosmopolitan Marketing & Operations Limited
Description of the Transaction: By reason of SJ Condit being a director of Cosmopolitan Marketing & Operations Limited
£
Balance at 01 August 2022 0
Balance at 31 July 2023 400,000
Name of the related party: Directors
Relationship:
Directors
Description of the Transaction: Included within other creditors is £29000 owed to the directors of the company
£
Balance at 01 August 2022 29,000
Balance at 31 July 2023 29,000

NORTHWEST MEDICAL LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

9. Post balance sheet events

There have been no significant events affecting the company since the year end.